FULCRUM THERAPEUTICS, INC.
Balance Sheet
| Line Item | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $86.7M | $39.9M | $25.6M | $30.1M | $34.0M | $34.7M | $35.1M | $90.9M |
| Accounts Receivable | — | — | — | — | — | — | — | — |
| Inventory | — | — | — | — | — | — | — | — |
| Total Current Assets | $280.3M | $218.0M | $242.2M | $262.5M | $282.9M | $302.8M | $207.5M | $227.7M |
| Property, Plant & Equipment | $4.4M | $4.8M | $5.2M | $5.6M | $6.2M | $6.6M | $6.9M | $7.4M |
| Goodwill | — | — | — | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | — | — | — | — | — | — | — | — |
| Total Assets | $294.3M | $232.6M | $257.7M | $278.9M | $300.3M | $321.1M | $226.7M | $247.8M |
| Liabilities | ||||||||
| Accounts Payable | $3.6M | $3.9M | $2.8M | $3.6M | $3.9M | $3.8M | $3.6M | $2.7M |
| Total Current Liabilities | $12.7M | $10.7M | $13.7M | $14.1M | $14.8M | $14.4M | $16.7M | $14.7M |
| Long-Term Debt | — | — | — | — | — | — | — | — |
| Total Liabilities | $20.5M | $19.0M | $22.5M | $23.4M | $24.9M | $24.9M | $27.7M | $26.4M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-481.1M | $-536.5M | $-509.7M | $-484.9M | $-460.9M | $-437.1M | $-412.3M | $-386.2M |
| Total Stockholders' Equity | $273.8M | $213.6M | $235.2M | $255.5M | $275.4M | $296.3M | $198.9M | $221.4M |